Dynatronics (NASDAQ:DYNT) is set to issue its quarterly earnings data after the market closes on Tuesday, February 13th.
Dynatronics (NASDAQ:DYNT) last released its quarterly earnings data on Tuesday, November 14th. The medical equipment provider reported $0.00 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.08. Dynatronics had a negative net margin of 3.42% and a negative return on equity of 45.78%. The business had revenue of $12.80 million during the quarter. On average, analysts expect Dynatronics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Dynatronics (NASDAQ:DYNT) traded up $0.41 during mid-day trading on Monday, hitting $3.00. 20,007 shares of the company traded hands, compared to its average volume of 17,538. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.92 and a current ratio of 1.46. Dynatronics has a 1-year low of $2.10 and a 1-year high of $3.75. The firm has a market cap of $12.76, a price-to-earnings ratio of -2.70 and a beta of -0.53.
Separately, Zacks Investment Research raised shares of Dynatronics from a “sell” rating to a “hold” rating in a research note on Tuesday, November 21st.
In other news, major shareholder Ventures 1 Lp Provco bought 300,000 shares of the business’s stock in a transaction on Thursday, November 30th. The stock was purchased at an average price of $2.50 per share, with a total value of $750,000.00. Following the transaction, the insider now directly owns 586,944 shares in the company, valued at $1,467,360. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Brian Larkin bought 40,000 shares of the business’s stock in a transaction on Thursday, November 30th. The shares were purchased at an average cost of $2.50 per share, with a total value of $100,000.00. Following the transaction, the director now owns 80,276 shares in the company, valued at $200,690. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 369,015 shares of company stock valued at $930,372. 51.80% of the stock is owned by company insiders.
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.